Association between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients

作者: J. Jung , E. Kang , J.M. Gwak , A.N. Seo , S.Y. Park

DOI: 10.3747/CO.23.3054

关键词:

摘要: Introduction BRCA mutation testing allows index patients and their families to be provided with appropriate cancer risk-reduction strategies. Because of the low prevalence mutations in unselected breast high cost genetic testing, it is important identify subset women who are likely carry mutations. In present study, we examined association between BRCA1 / 2 germline immunohistochemical features cancer. Methods a retrospective review 498 had undergone at Seoul National University Bundang Hospital July 2003 September 2012, gathered information on estrogen receptor (er), progesterone (pr), her2 (human epidermal growth factor 2), cytokeratin 5/6, egfr (epidermal receptor), p53 status. Results Among 411 eligible for 50 (12.2%) or BRCA2 . Of 93 triple-negative (tnbc), 25 were identified ( BRCA1, 20.4%; BRCA2, 6.5%). On univariate analysis, er, pr, egfr, tnbc found related mutations, but multivariate only was significantly associated early-onset family history ovarian cancer, more prevalent group than non-tnbc group. Conclusions independent predictor risk hereditary cancers. Other histologic basal-like did not improve estimate risk.

参考文章(21)
Axel Muendlein, Bettina H. Rohde, Klaus Gasser, Anton Haid, Stephanie Rauch, Elena Kinz, Heinz Drexel, Wera Hofmann, Verena Schindler, Rita Kapoor, Thomas Decker, Alois H. Lang, Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer Journal of Cancer Research and Clinical Oncology. ,vol. 141, pp. 2005- 2012 ,(2015) , 10.1007/S00432-015-1986-2
C. Villarreal-Garza, J. N. Weitzel, M. Llacuachaqui, E. Sifuentes, M. C. Magallanes-Hoyos, L. Gallardo, R. M. Alvarez-Gómez, J. Herzog, D. Castillo, R. Royer, Mohammad Akbari, F. Lara-Medina, L. A. Herrera, A. Mohar, S. A. Narod, The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer. Breast Cancer Research and Treatment. ,vol. 150, pp. 389- 394 ,(2015) , 10.1007/S10549-015-3312-8
Priyanka Sharma, Jennifer R. Klemp, Bruce F. Kimler, Jonathan D. Mahnken, Larry J. Geier, Qamar J. Khan, Manana Elia, Carol S. Connor, Marilee K. McGinness, Joshua M. W. Mammen, Jamie L. Wagner, Claire Ward, Lori Ranallo, Catherine J. Knight, Shane R. Stecklein, Roy A. Jensen, Carol J. Fabian, Andrew K. Godwin, Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing Breast Cancer Research and Treatment. ,vol. 145, pp. 707- 714 ,(2014) , 10.1007/S10549-014-2980-0
N C Turner, J S Reis-Filho, Basal-like breast cancer and the BRCA1 phenotype. Oncogene. ,vol. 25, pp. 5846- 5853 ,(2006) , 10.1038/SJ.ONC.1209876
L Robertson, , H Hanson, S Seal, M Warren-Perry, D Hughes, I Howell, C Turnbull, R Houlston, S Shanley, S Butler, D G Evans, G Ross, D Eccles, A Tutt, N Rahman, BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years British Journal of Cancer. ,vol. 106, pp. 1234- 1238 ,(2012) , 10.1038/BJC.2012.31
Seth Rummel, Erika Varner, Craig D. Shriver, Rachel E. Ellsworth, Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer Breast Cancer Research and Treatment. ,vol. 137, pp. 119- 125 ,(2013) , 10.1007/S10549-012-2348-2
Lisa A. Newman, Jorge S. Reis-Filho, Monica Morrow, Lisa A. Carey, Tari A. King, The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer. Annals of Surgical Oncology. ,vol. 22, pp. 874- 882 ,(2015) , 10.1245/S10434-014-4279-0
Laura C. Collins, Anthony Martyniak, Michaela J. Kandel, Zsofia K. Stadler, Serena Masciari, Alexander Miron, Andrea L. Richardson, Stuart J. Schnitt, Judy E. Garber, Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers The American Journal of Surgical Pathology. ,vol. 33, pp. 1093- 1097 ,(2009) , 10.1097/PAS.0B013E31819C1C93
Sze-Yee Phuah, Lai-Meng Looi, Norhashimah Hassan, Anthony Rhodes, Sarah Dean, Nur Aishah Mohd Taib, Cheng-Har Yip, Soo-Hwang Teo, Triple-negative breast cancer and PTEN (phosphatase and tensin homologue)loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer Breast Cancer Research. ,vol. 14, pp. 1- 9 ,(2012) , 10.1186/BCR3347
J. Lorenzo Bermejo, K. Hemminki, Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing Annals of Oncology. ,vol. 15, pp. 1834- 1841 ,(2004) , 10.1093/ANNONC/MDH474